Celldex is now “prioritizing” its pipeline and the company ... The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection. RDInvesting has not been compensated; directly or …
Hampton, NJ-based Celldex Therapeutics, Inc. CLDX is a biopharmaceutical company developing immunotherapy technologies and other cancer-targeting biologics. The company is still in development stage and does not have any …
For Celldex Therapeutics (NASDAQ: CLDX), 2016 was a horrible year. The biotech stock dropped 77% after experimental vaccine Rintega flopped in a late-stage clinical study. Celldex entered 2017 with investors having both hope and fear. …